Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis

Overview of attention for article published in PLOS ONE, November 2012

Altmetric Badge

Mentioned by

twitter: 6 X users

f1000: 1 research highlight platform

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 25 Mendeley

Summary X Research highlights Dimensions citations

So far, Dimensions has found 22 publications that cite this research output.

22

The most recent citing publications are shown below. View all 22 publications that cite this research output on Dimensions.

Inflammatory Bowel Diseases and Non-Alcoholic Fatty Liver Disease: Piecing a Complex Puzzle Together

Article in International Journal of Molecular Sciences (March 2024)

The impact of nonalcoholic fatty liver disease on inflammatory bowel disease-related hospitalization outcomes: a systematic review

Article in European Journal of Gastroenterology & Hepatology (July 2023)

The FXR mediated anti-depression effect of CDCA underpinned its therapeutic potentiation for MDD

Article in International Immunopharmacology (December 2022)